Literature DB >> 18462223

Presentation and prognosis of local recurrence after total mesorectal excision.

C de Chaisemartin1, C Penna, D Goere, S Benoist, A Beauchet, C Julie, B Nordlinger.   

Abstract

OBJECTIVE: The aim of this study was to describe the presentation, treatment and prognosis of local recurrences following total mesorectal excision for rectal adenocarcinoma.
METHOD: Between 1999 and 2002, 201 patients were treated with total mesorectal excision for mid or low rectal cancer and were followed up prospectively.
RESULTS: Overall 2-year survival was 85%. The 2-year recurrence rate was 8%. Eighteen patients developed local recurrence at 3-60 months. Nine recurrences originated from the pelvic sidewall. These recurrences were symptomatic in 90% of patients. Only two patients were reoperated with a R0 resection and were alive without local recurrence after 19 and 31 months. The seven others died within 9 months. Nine recurrences originated from an anastomotic suture line. Only two had symptoms. A R0 surgical resection was performed in all patients with a 67% sphincter conservation rate. After 26-months of median follow-up (range 7-58), all patients were alive.
CONCLUSION: Half of the local recurrence after total mesorectal excision was located at the anastomotic site. Rectoscopic examination should be performed regularly to detect these anatomotic recurrences that are accessible to a R0 itérative resection.

Entities:  

Mesh:

Year:  2008        PMID: 18462223     DOI: 10.1111/j.1463-1318.2008.01537.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  12 in total

1.  Clinicopathological features of anastomotic recurrence after an anterior resection for rectal cancer.

Authors:  Kenji Matsuda; Tsukasa Hotta; Katsunari Takifuji; Shozo Yokoyama; Yoshimasa Oku; Hiroki Yamaue
Journal:  Langenbecks Arch Surg       Date:  2009-06-10       Impact factor: 3.445

2.  Post-chemoradiation anastomotic recurrence in locally advanced rectal cancer: no increased risk associated with distal margin.

Authors:  F A Calvo; F Rivas; C V Sole; M Gómez-Espí; R Herranz; E Del Valle; M Rodríguez; E Alvarez
Journal:  Clin Transl Oncol       Date:  2013-10-16       Impact factor: 3.405

3.  Impact of anatomic location on locally recurrent rectal cancer: superior outcome for intraluminal tumour recurrence.

Authors:  Johannes Klose; Ignazio Tarantino; Thomas Schmidt; Thomas Bruckner; Yakup Kulu; Tobias Wagner; Martin Schneider; Markus W Büchler; Alexis Ulrich
Journal:  J Gastrointest Surg       Date:  2015-03-31       Impact factor: 3.452

Review 4.  The role of lateral lymph node dissection in the management of lower rectal cancer.

Authors:  Ziting Wang; Kep Yong Loh; Kok-Yang Tan; Emile Chung-Hou Woo
Journal:  Langenbecks Arch Surg       Date:  2011-11-22       Impact factor: 3.445

5.  The effect of increased body mass index values on surgical outcomes after radical resection for low rectal cancer.

Authors:  Xubing Zhang; Qingbin Wu; Chaoyang Gu; Tao Hu; Liang Bi; Ziqiang Wang
Journal:  Surg Today       Date:  2019-02-18       Impact factor: 2.549

6.  Intensity-modulated radiation therapy for pelvic oligo-recurrence from rectal cancer: long-term results from a single institution.

Authors:  Xiang-Gao Zhu; Yong-Heng Li; Xiao-Fan Li; Yong Cai
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

7.  [Total pelvic exenteration].

Authors:  U Heger; M Koch; M W Büchler; J Weitz
Journal:  Chirurg       Date:  2010-10       Impact factor: 0.955

8.  Prognostic value of quality of life and pain in patients with locally recurrent rectal cancer.

Authors:  Y Nancy You; Halim Habiba; George J Chang; Miguel A Rodriguez-bigas; John M Skibber
Journal:  Ann Surg Oncol       Date:  2010-12-04       Impact factor: 5.344

Review 9.  [Therapy of locally recurrent rectal carcinoma].

Authors:  H G Hempen; H R Raab
Journal:  Chirurg       Date:  2009-04       Impact factor: 0.955

Review 10.  Intentionally curative treatment of locally recurrent rectal cancer: a systematic review.

Authors:  Pieter J Tanis; Annemiek Doeksen; J Jan B van Lanschot
Journal:  Can J Surg       Date:  2013-04       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.